ESCMID eLibrary

Search results
Icon explanation








-
eP259
Optimising antifungal combination therapy of voriconazole+amphotericin B against Aspergillus fumigatus using a pharmacokinetic-pharmacodynamic (PK-PD) model
10 May 2014
Session: Antifungal drug susceptibility and resistance
-
P0010
In vivo efficacy of a JAK1/2 inhibitor in a murine model of haematogenously disseminated candidiasis
10 May 2014
Session: News from the fungal frontier
-
R130
Evaluation of 3h vs 6h continuous infusion regimens against carbapenemase-producing K. pneumoniae isolates using an in vitro pharmacokinetic-pharmacodynamic model
10 May 2014
Session: Antimicrobials: In vitro antibacterial susceptibility and drug interaction studies
-
P1583
Agreement of MIC test strips®, Etest® and the EUCAST broth microdilution method for Candida spp. antifungal susceptibility testing
28 April 2013
Session: EUCAST breakpoints and methodology for antimicrobial susceptibility testing
-
P1082
Posaconazole pharmacodynamics against azole-resistant Aspergillus fumigatus strains with a novel in vitro pharmacokinetic/pharmacodynamic model
27 April 2013
Session: Mycology: from bedside to bench
-
P976
Evaluation of gradient concentration strips for in vitro combination testing of antifungal combinations against Candida spp.
27 April 2013
Session: Antifungal resistance: perspectives and practice
-
P982
Comparative evaluation of Sensititre YeastOne and CLSI M38-A2 reference method for echinocandin susceptibility testing of Aspergillus spp.
27 April 2013
Session: Antifungal resistance: perspectives and practice
-
Simulating in vivo conditions in in vitro PK/PD models.
10 October 2012
-
Pharmacodynamic analysis.
09 October 2012
-
O307
Determination of azole resistance among Aspergillus fumigatus by studying in vitro pharmacodynamics of voriconazole with a novel pharmacokinetic/pharmacodynamic model
01 April 2012
Session: Considering pharmacodynamic effects in antifungal treatment strategies
Search narrowed by
-
Topics
-
Type of material
-
Time period